Enoxaparin Sodium Injection Pre Filled Syringe with Sycure AD (20mg/0.2mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL)

  • Enoxaparin Sodium Injection Pre Filled Syringe with Sycure AD (20mg/0.2mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL) 1
  • Enoxaparin Sodium Injection Pre Filled Syringe with Sycure AD (20mg/0.2mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL) 2
  • Enoxaparin Sodium Injection Pre Filled Syringe with Sycure AD (20mg/0.2mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL) 3
Product Description

Enoxaparin injection is an anticoagulant primarily indicated for the prevention of deep vein thrombosis (DVT), which can lead to life-threatening pulmonary embolisms (blood clots in the lungs).

Read more Show less

Kaisha Lifesciences Pvt. Ltd

  • Country/Region:
    India
  • On CPHI since:
    2019
  • Employees:
    25 - 49
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
View company profile
Categories
more categories Show less
Specifications
  • Details
    CTD Dossier - Ready with Zone IVb Stability Studies Primary Container - 1 mL Pre-Filled Syringe with Sycure AD 
    Pack Size - 1 PFS packed in Blister, 1 such Blister packed in Monocarton (1 PFS in Monocarton) 
    Shelf Life - 24 months (Extended Stability Data available till 30 Months) 
    Process Type - Aseptically Sterilized 
    API Grade - USDMF 
    GMP Approval - EU Hungary, ANIVSA Brazil 


     Sycure AD (Plunger Rod Auto Locking Device) 


    • Automatic Plunger Lock: Once the full dose is administered, the plunger rod securely locks into the plastic attachment. Unlike a standard syringe, the plunger cannot be re-engaged or pulled back to draw another dose. 
    • Audible "Click" Confirmation: A distinct click sound signals to both the healthcare provider and the patient that the entire dose has been successfully delivered and the system is safely locked. 
     • Extended Finger Flanges: Features a larger finger-gripping portion that provides doctors and nurses with a more secure, firm, and stable grip during injection.
  • Model
    Finished Dosage Forms
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

Kaisha Lifesciences Pvt. Ltd

  • Country/Region:
    India
  • On CPHI since:
    2019
  • Employees:
    25 - 49
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
View company profile

More Products from Kaisha Lifesciences Pvt. Ltd (3)

  • Ondansetron Injection BP (4 mg/2 mL, 8mg/4mL)

    Product Ondansetron Injection BP (4 mg/2 mL, 8mg/4mL)

    CTD Dossier - Ready with Zone IVb Stability Studies Primary Container - 2 mL / 5mL USP Type 1 Glass Ampoule Pack Size - 20 Ampoules in Tray, packed in Monocarton with Insert (20 Ampoules in Monocarton) Shelf Life - 24 months (Extended Stability Data available till 36 Months) Process Type - Terminally Steri...
  • Oxytocin Injection BP (5 IU/0.5mL, 5 IU/1mL, 10 IU/1mL)

    Product Oxytocin Injection BP (5 IU/0.5mL, 5 IU/1mL, 10 IU/1mL)

    CTD Dossier - Ready with Zone IVb Stability Studies Primary Container - 1 mL USP Type 1 Glass Ampoule Pack Size - 5 Ampoules packed in Blister, 15 such Blisters packed in Monocarton with Insert (75 Ampoules in Monocarton) Shelf Life - 24 months (Extended Stability Data available till 36 Months) Process Ty...
  • Pantoprazole for Injection BP 40 mg/vial (Unit Lyophilized)

    Product Pantoprazole for Injection BP 40 mg/vial (Unit Lyophilized)

    CTD Dossier - Ready with Zone IVb Stability Studies Primary Container - 10 mL USP Type 1 Glass Vial Pack Size - 1 Vial packed in Monocarton with Insert Shelf Life - 24 months (Extended Stability Data available till 30 Months) Process Type - Aseptically Sterilized GMP Approval - EU Hungary, ANIVSA Brazil

Kaisha Lifesciences Pvt. Ltd resources (4)